Camtek Ltd. Insider Trading

CAMT

Last 12 months

Insiders sold $5.1M and bought nothing on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. Director Lior Aviram sold $1.13M on Aug 12, 35% of their stake, outside a plan. No executive or director has bought shares on the open market in the last two years.

Net open-market

−$5.1M

0 buys · 7 sales

Under a 10b5-1 plan

of the value sold

Insiders who bought / sold

0 / 6

executives and directors

Last open-market buy

None

in the last two years

Get an email when CAMT's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Aug 17	Orit Geva-Dvash Vice President, HR	SoldNo plan	508	$175.00	89K	8.9%	Form 4
Aug 13 – 14	Karni Yarl Andorn Director	SoldNo plan 3 parts	5,532	$167.79 average	928K	80%	Form 4
Aug 13	Ram Langer Chief Operating Officer	SoldNo plan	6,387	$172.32	$1.1M	27%	Form 4
Aug 13	Rafi Amit Chief Executive Officer	SoldNo plan	6,250	$170.52	$1.07M	10%	Form 4
Aug 12	Orit Geva-Dvash Vice President, HR	SoldNo plan	415	$174.06	72K	6.8%	Form 4
Aug 11 – 12	Lior Aviram Director	SoldNo plan 4 parts	6,694	$168.43 average	$1.13M	35%	Form 4
Aug 11 – 12	Moshe Eisenberg Chief Financial Officer	SoldNo plan 2 parts	4,404	$161.91 average	713K	21%	Form 4

Aug 17No plan
Orit Geva-Dvash
Vice President, HR · sold 508 at $175.00
89K
8.9% of stake
Aug 13 – 14No plan
Karni Yarl Andorn
Director · sold 5,532 at avg $167.79
928K
80% of stake
Aug 13No plan
Ram Langer
Chief Operating Officer · sold 6,387 at $172.32
$1.1M
27% of stake
Aug 13No plan
Rafi Amit
Chief Executive Officer · sold 6,250 at $170.52
$1.07M
10% of stake
Aug 12No plan
Orit Geva-Dvash
Vice President, HR · sold 415 at $174.06
72K
6.8% of stake
Aug 11 – 12No plan
Lior Aviram
Director · sold 6,694 at avg $168.43
$1.13M
35% of stake
Aug 11 – 12No plan
Moshe Eisenberg
Chief Financial Officer · sold 4,404 at avg $161.91
713K
21% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch CAMT, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Optical Instruments & Lenses · Pick stocks to compare with CAMT

CompareIntrinsic value

NVMINova Ltd.

$295.35-2.43%67

COHUCohu Inc.

$43.98-12.09%16

ALNTAllient Inc

$79.56-9.61%31

TXG10x Genomics Inc.

$67.52+3.42%48

TRNSTranscat Inc.

$108.13+20.79%40

KEQUKewaunee Scientific Corporation

$33.83+1.29%64

MLABMesa Laboratories Inc.

$126.19+0.57%59

CTKBCytek Biosciences, Inc.

$5.88-1.34%50

Held by ETFs

CAMT is in 27 US ETFs. The largest of them, with CAMT's weight in each:

Spot a number that looks wrong? Check it in CAMT's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing CAMT

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.